In support of the Global Liver Institute campaign for International NASH Day, NASHNET developed a groundbreaking white paper titled “Biomarkers for Diagnosing and Staging Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): Current Perspectives and Potential Future Applications.” The white paper sheds light on guideline-directed and optimal use of biomarkers to diagnose or stage NASH. Special thanks… Continue reading NASHNET Biomarkers White Paper
Tag: NASH
NASHNET Designates Eighth Center of Excellence for Nonalcoholic Steatohepatitis
NEW YORK, January 9, 2020 – Eight leading care delivery systems from across the country have been designated as founding charter members of NASHNET and Centers of Excellence (COEs).
The Kinetix Group has Been Recognized by Medical Marketing & Media as a Top 100 Healthcare Agency
NEW YORK, July 18, 2019 – The Kinetix Group (TKG), a New York City-based life sciences marketing agency and care delivery consultancy, has been recognized by Medical Marketing & Media (MM&M) as a top 100 healthcare agency.
The Kinetix Group and Consulting at McCann Health’s Research Report on Quality Measures for Nonalcoholic Steatohepatitis (NASH) to Be Presented at ISPOR 2019
NEW YORK, March 26, 2019 – The Kinetix Group, in partnership with Consulting at McCann Health, has authored a research report that has been accepted to be exhibited as a poster presentation at ISPOR 2019 in New Orleans on May 20, 2019. The report is titled, “Which Outcome & Quality Measures Do Leading KOLs Who Treat Nonalcoholic Steatohepatitis (NASH) Recommend flor Value-Based Contracting Across Multiple Stakeholders?”, and analyzes primary and secondary research, including insights gathered from 12 US key opinion leaders (KOLs).
The Kinetix Group Partners with Rimidi to Launch a Clinical Care Partnership for the Management of Nonalcoholic Steatohepatitis (NASH)
NEW YORK, August 30, 2018 – The Kinetix Group in partnership with Rimidi, an Atlanta-based health care technology firm, announced a partnership focused on improving Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) care delivery leveraging NASHNET, a global centers of excellence network.
The Nonalcoholic Steatohepatitis (NASH) Network in Collaboration with Echosens Launches a Real World Evidence Model
NEW YORK, August 23, 2018 – The global NASH market is projected to reach $21.5 billion by 2025, with NASH being the leading cause of liver transplantation in the US in the coming years. 1 The NASH Network (NASHNET), in collaboration with The Kinetix Group, has launched a Real World Evidence study to optimize care delivery for patients with Non-Alcoholic Steatohepatitis (NASH). This initiative is in partnership with Echosens, the innovators and marketers of the FibroScan® family of products.
The Nonalcoholic Steatohepatitis (NASH) Network in Collaboration with The Kinetix Group Participates in the International Liver Congress 2018
NEW YORK, April 6, 2018 – The NASH Network (NASHNET), in collaboration with The Kinetix Group is focused on improving NASH care delivery by collaboration on innovation, best practice sharing, and real world research. NASHNET will be participating at the upcoming International Liver Congress, hosted by the European Association for the Study of the Liver (EASL) on April 11th – 15th at Paris Expo Porte de Versailles in Paris, France.
TKG establishes NASH Centers of Excellence Network to Improve Care Delivery and Achieve the Quadruple Aim
Nonalcoholic Steatohepatitis (NASH) has been identified as a challenging high volume chronic disease without a standardized care delivery model. A national NASH Centers of Excellence Network (NCEN) has been designed to build best practices necessary for NASH care delivery design. The Kinetix Group’s Care Delivery Division provides the operational and strategic support for the NCEN.… Continue reading TKG establishes NASH Centers of Excellence Network to Improve Care Delivery and Achieve the Quadruple Aim
The Kinetix Group (TKG) establishes NASH Centers of Excellence Network to Improve Care Delivery and Achieve the Quadruple Aim
NEW YORK, November 29, 2017 – Nonalcoholic Steatohepatitis (NASH) has been identified as a challenging high volume chronic disease without a standardized care delivery model. A national NASH Centers of Excellence Network (NCEN) has been designed to build best practices necessary for NASH care delivery design. The Kinetix Group’s Care Delivery Division provides the operational and strategic support for the NCEN. The initial members of the NCEN include Geisinger Health System, Ochsner Medical Center, Mount Sinai Hospital, Cedars-Sinai Health System, and Baylor Medical College, with a commitment to improve NASH care delivery.